NCT05362292View on ClinicalTrials.gov

TReating Incontinence for Underlying Mental and Physical Health

PHASE4RecruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

October 4, 2022

Primary Completion Date

November 2, 2026

Study Completion Date

January 25, 2027

Conditions
Urinary Incontinence, UrgeUrinary IncontinenceOveractive BladderIncontinence, UrgeIncontinence, UrinaryIncontinence
Interventions
DRUG

Tolterodine Tartrate ER

Anticholinergic

DRUG

Mirabegron

Beta-3-adrenergic agonist

DRUG

Placebo

matching placebo pill

Trial Locations (2)

94115

RECRUITING

University of California San Francisco, San Francisco

94305

RECRUITING

Stanford University, Palo Alto

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, San Francisco

OTHER